18 July 2023
18 July 2023
The FDA says that reports of the blood test showing falsely low troponin levels pose a particular risk to patients who experience ‘silent’ heart attacks.
The patented features comprise video analytics and bandwidth preservation.
Shares in Eroxon’s manufacturer Futura Medical rose by 12% after the partnership announcement.
The device is compatible with commercially available endovascular snares, vascular sheaths and other graspers.
The new assays enable preimplantation genetic testing-aneuploidy used to inform ICSI and IVF research.
Issues with the device rerouting power after depleting its battery mean it could stop ventilating patients, despite an alarm alert.
The partnership will initially focus on further validating AccuStem’s StemPrintER test for breast cancer patients.
The study has demonstrated 90% patient improvement, sustained for two years.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
